PDF(Pubmed)
Abstract：
Type 2 diabetes mellitus (T2D) poses a significant global health challenge and demands effective self-management strategies, including continuous blood glucose monitoring (CGM) and lifestyle adaptations. While CGM offers real-time glucose level assessment, the quest for minimizing trauma and enhancing convenience has spurred the need to explore non-invasive alternatives for monitoring vital signs in patients with T2D. Objective: This systematic review is the first that explores the current literature and critically evaluates the use and reporting of non-invasive wearable devices for monitoring vital signs in patients with T2D. Methods: Employing the PRISMA and PICOS guidelines, we conducted a comprehensive search to incorporate evidence from relevant studies, focusing on randomized controlled trials (RCTs), systematic reviews, and meta-analyses published since 2017. Of the 437 publications identified, seven were selected based on predetermined criteria. Results: The seven studies included in this review used various sensing technologies, such as heart rate monitors, accelerometers, and other wearable devices. Primary health outcomes included blood pressure measurements, heart rate, body fat percentage, and cardiorespiratory endurance. Non-invasive wearable devices demonstrated potential for aiding T2D management, albeit with variations in efficacy across studies. Conclusions: Based on the low number of studies with higher evidence levels (i.e., RCTs) that we were able to find and the significant differences in design between these studies, we conclude that further evidence is required to validate the application, efficacy, and real-world impact of these wearable devices. Emphasizing transparency in bias reporting and conducting in-depth research is crucial for fully understanding the implications and benefits of wearable devices in T2D management.
摘要：
2型糖尿病（T2D）构成了重大的全球健康挑战，需要有效的自我管理策略。包括连续血糖监测（CGM）和生活方式适应。虽然CGM提供实时血糖水平评估，对最小化创伤和提高便利性的追求促使人们需要探索用于监测T2D患者生命体征的非侵入性替代方法.目的：本系统综述首次探讨了当前文献，并严格评估了无创可穿戴设备在T2D患者生命体征监测中的使用和报告。方法：采用PRISMA和PICOS指南，我们进行了全面的搜索，以纳入相关研究的证据，专注于随机对照试验（RCT），系统评价,以及自2017年以来发表的荟萃分析。在确定的437种出版物中，根据预定标准选择了7个。结果：这篇综述中包含的七项研究使用了各种传感技术，如心率监测器，加速度计,和其他可穿戴设备。主要的健康结果包括血压测量，心率,身体脂肪百分比，和心肺耐力。非侵入式可穿戴设备显示出帮助T2D管理的潜力，尽管不同研究的疗效存在差异。结论：基于证据水平较高的研究数量较少(即，RCT)，我们能够发现这些研究之间的设计和显著差异，我们得出结论，需要进一步的证据来验证申请，功效,以及这些可穿戴设备对现实世界的影响。强调偏见报告的透明度并进行深入的研究对于充分理解可穿戴设备在T2D管理中的影响和好处至关重要。
